|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 388 of 621 found articles
| Title: |
Phase II California Cancer Consortium trial of gemcitabine–eribulin combination (GE) in cisplatin ineligible patients (pts) with metastatic urothelial carcinoma (mUC): tolerability and toxicity report (NCI-9653; 1UM1CA186717-01, NO1-CM-2011-00038) |
| Author: |
Sadeghi, S. Groshen, S. Parikh, R. Mortazavi, A. Dorff, T. Hoimes, C. Pal, S. Levine, E. Doyle, L. Quinn, D. Newman, E. Lara, P. |
| Appeared in: |
European journal of cancer |
| Paging: | Volume 72 (2017) nr. S1 pages S197 |
| Year: |
2017 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 388 of 621 found articles
| << previous | next >> |